The run-up in equity prices related to the COVID-19 outbreak combined with the federal government's efforts to soften the financial damage due to the pandemic have driven equity prices sharply higher. Inevitably,…
The June 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Gilead has priced its COVID-19 drug candidate at $2,340 for a five-day treatment in the United States and some other developed countries. The company set the price for a single vial of…
Chris Lange The June 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
The new attitude among investors about sustainability and societal impact probably will dominate discussion and investment choices in the years to come. Here are five of RBC's top picks in the arena…
The May 29 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Wednesday's top analyst upgrades and downgrades included Apache, Apple, CME, Devon Energy, Diamondback Energy, Gilead Sciences, Hexo, MarketAxess, Microchip Technology and Zoom Video Communications.
The May 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks was mixed.
In a world where investors are starving to find growth, many of the well established biotech leaders and many of the large pharmaceutical companies have been acquiring growth on top of their…
Tuesday's top analyst upgrades and downgrades included Chembio Diagnostics, Cognex, Cree, Deere, Gilead Sciences, Halliburton, iRobot, Lam Research, Nvidia, Regeneron Pharmaceuticals, Sorrento Therapeutics and Take-Two Interactive Software.
Tuesday's top analyst upgrades and downgrades included Beyond Meat, BioNTech, Comcast, DraftKings, Expedia, Gap, Gilead Sciences, Hess, Lululemon Athletica, Newmont and Royal Gold.
The April 30 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Gilead Sciences took another big step forward in its treatment for COVID-19 on Friday when a Japanese regulatory body approved that treatment.
Chris Lange Monday's top analyst upgrades and downgrades included Amazon.com, American Airlines, American Express, Beyond Meat, Caterpillar, Clorox, eBay, Gilead Sciences, Twitter, Verizon Communications and Wayfair.
The April 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
